BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12684116)

  • 1. Spectrophotometric and titrimetric determination of nizatidine in capsules.
    El-Yazbi FA; Gazy AA; Mahgoub H; El-Sayed MA; Youssef RM
    J Pharm Biomed Anal; 2003 Apr; 31(5):1027-34. PubMed ID: 12684116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic spectrophotometric method for the determination of ranitidine and nizatidine in pharmaceuticals.
    Walash MI; Belal F; Ibrahim F; Hefnawy M; Eid M
    J AOAC Int; 2002; 85(6):1316-23. PubMed ID: 12477194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic spectrophotometric determination of nizatidine and ranitidine in pharmaceutical preparations.
    Hassan EM; Belal F
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):31-8. PubMed ID: 11682208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrophotometric determination of H(2)-receptor antagonists via their oxidation with cerium(IV).
    Darwish IA; Hussein SA; Mahmoud AM; Hassan AI
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):33-40. PubMed ID: 17442613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive spectrophotometric method for the determination of H2-receptor antagonists by means of N-bromosuccinimide and p-aminophenol.
    Darwish IA; Hussein SA; Mahmoud AM; Hassan AI
    Acta Pharm; 2008 Mar; 58(1):87-97. PubMed ID: 18337210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrophotometric determination of nizatidine and ranitidine through charge transfer complex formation.
    Walash M; Sharaf-El Din M; Metwalli ME; RedaShabana M
    Arch Pharm Res; 2004 Jul; 27(7):720-6. PubMed ID: 15356997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a new high-performance liquid chromatography assay for nizatidine.
    Yusuf A; Al Dgither S; Hammami MM
    Ther Drug Monit; 2006 Apr; 28(2):232-6. PubMed ID: 16628136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrophotometric determination of nizatidine in pharmaceutical preparations.
    Minic D; Petkovic J; Koricanac Z; Jovanovic T
    J Pharm Biomed Anal; 1996 Jun; 14(8-10):1355-8. PubMed ID: 8818056
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid titrimetric and spectrophotometric methods for salbutamol sulphate in pharmaceuticals using N-bromosuccinimide.
    Basavaiah K; Somashekar BC; Ramakrishna V
    Acta Pharm; 2007 Mar; 57(1):87-98. PubMed ID: 19839409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of cimetidine, famotidine, nizatidine, and ranitidine in tablets by capillary zone electrophoresis.
    Wu SM; Ho YH; Wu HL; Chen SH; Ko HS
    Electrophoresis; 2001 Aug; 22(13):2758-62. PubMed ID: 11545404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of some histamine H1-receptor antagonists in dosage forms.
    Gazy AA; Mahgoub H; El-Yazbi FA; El-Sayed MA; Youssef RM
    J Pharm Biomed Anal; 2002 Oct; 30(3):859-67. PubMed ID: 12367712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated stability-indicating methods for the determination of nizatidine in the presence of its sulfoxide derivative.
    Youssef RM
    J AOAC Int; 2008; 91(1):73-82. PubMed ID: 18376588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Validated Comparative Stability-Indicating Assay Method for Some H2-Receptor Antagonists.
    Ahmed S; Elshaboury SR; Mohamed NA; Farrag S
    J Chromatogr Sci; 2017 Sep; 55(8):818-831. PubMed ID: 28486578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrophotometric determination of three anti-ulcer drugs through charge-transfer complexation.
    Al-Ghannam S; Belal F
    J AOAC Int; 2002; 85(5):1003-8. PubMed ID: 12374395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic spectrophotometric determination of famotidine in commercial dosage forms.
    Rahman N; Kashif M
    Anal Sci; 2003 Jun; 19(6):907-11. PubMed ID: 12834233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive indirect spectrophotometric method for determination of h2-receptor antagonists in pharmaceutical formulations.
    Darwish IA; Hussein SA; Mahmoud AM; Hassan AI
    Int J Biomed Sci; 2007 Jun; 3(2):123-30. PubMed ID: 23675034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of non-aqueous capillary zone electrophoresis for the determination of histamine H2 receptor antagonists in pharmaceuticals.
    Nevado JJ; Peñalvo GC; Dorado RM
    Anal Sci; 2011; 27(4):427. PubMed ID: 21478620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrophotometric determination of enoxacin as ion-pairs with bromophenol blue and bromocresol purple in bulk and pharmaceutical dosage form.
    Süslü I; Tamer A
    J Pharm Biomed Anal; 2002 Jul; 29(3):545-54. PubMed ID: 12062655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of ranitidine, nizatidine, and cimetidine by a sensitive fluorescent probe.
    Chang YX; Qiu YQ; Du LM; Li CF; Guo M
    Analyst; 2011 Oct; 136(20):4168-73. PubMed ID: 21858296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential pulse polarographic determination of nizatidine in pharmaceutical formulations.
    Kapetanović V; Milovanović L; Vladimirov S
    Farmaco; 1994 May; 49(5):377-9. PubMed ID: 8080623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.